Xue‐Fang Peng

机构：Wuhan Institute of Virology, Weihai Chest Hospital · ORCID：0000-0002-4817-3117

发表论文 18 篇 · 总被引 462 次 · h-index 10

代表论文

• Single-cell landscape of peripheral immune responses to fatal SFTS (2021 · Cell Reports · 被引 103)
• A systematic meta‐analysis of immune signatures in patients with COVID‐19 (2020 · Reviews in Medical Virology · 被引 72)
• Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome (2021 · EBioMedicine · 被引 60)
• Effect of genomic variations in severe fever with thrombocytopenia syndrome virus on the disease lethality (2022 · Emerging Microbes & Infections · 被引 57)
• CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus (2023 · Science Advances · 被引 52)
• Dynamics of neutralizing antibodies against severe fever with thrombocytopenia syndrome virus (2023 · International Journal of Infectious Diseases · 被引 24)